Stock CTSO CYTOSORBENTS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cytosorbents Corporation

Equities

CTSO

US23283X2062

Real-time Estimate Cboe BZX
Other stock markets
 12:11:56 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.81 USD +1.12% Intraday chart for Cytosorbents Corporation -6.73% -26.73%
Mar. 15 Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 14 Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M MT

Evolution of the average Target Price on Cytosorbents Corporation

Price target over the last 5 years

History of analyst recommendation changes

1ef3c3.xex0DLt3RUlV6zTGZ7GyqGSqbn6sOjfpV0OFOrB_YEA.gtQyepYzBno2mkOjVceDy1HAKUfhA3rZICvTfYYIEgbytTY7_04VI2epfQ~3916b3d893a2d0c045870f1411c6d9e4

Analyst Recommendations on Cytosorbents Corporation

HC Wainwright Downgrades Cytosorbents to Neutral From Buy, Cuts Price Target to $1 From $5.50 MT
B. Riley Trims Price Target on Cytosorbents to $3 From $4, Maintains Buy Rating MT
US STOCKS -Wall Street edges higher as year end approaches, rate cuts in focus RE
B. Riley Resumes Cytosorbents at Buy With $4 PT; Notes CytoSorb's Growth Potential, Risk-Adjusted Revenue Contribution of DrugSorb-ATR in US MT
HC Wainwright Adjusts Price Target on Cytosorbents to $5.50 From $9, Maintains Buy Rating MT
B. Riley Trims Cytosorbents' Price Target to $6 from $7, Lowers Revenue Estimates Despite Confidence for Mid-Term; Keeps Buy Rating MT
HC Wainwright Adjusts Cytosorbents' Price Target to $9 from $13, Keeps Buy Rating MT
B. Riley Lowers Cytosorbents' Price Target to $7 from $10, Notes Continued H1 Headwinds, Lowers Revenue Estimate for 2022; Keeps Buy Rating MT
CYTOSORBENTS : B. Riley Resumes Cytosorbents at Buy with $10 PT, Says Headwinds Represent Buying Opportunity MT
CYTOSORBENTS : B. Riley Adjusts Cytosorbents' Price Target to $17 From $16, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.801 USD
Average target price
2.667 USD
Spread / Average Target
+232.92%
High Price Target
4 USD
Spread / Highest target
+399.38%
Low Price Target
1 USD
Spread / Lowest Target
+24.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cytosorbents Corporation

HC Wainwright
B. Riley

Ratings for Cytosorbents Corporation

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CTSO Stock
  4. Consensus Cytosorbents Corporation